The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized, double-blind, placebo-controlled phase III study of apatinib or placebo plus gefitinib as first-line treatment in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC).
 
Hongyun Zhao
No Relationships to Disclose
 
Zhonghan Zhang
No Relationships to Disclose
 
Fan Luo
No Relationships to Disclose
 
Yuxiang Ma
No Relationships to Disclose
 
Wenfeng Fang
No Relationships to Disclose
 
Yunpeng Yang
No Relationships to Disclose
 
Yang Zhang
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Li Zhang
No Relationships to Disclose